Showing results (1981-1990 of 2,921) with videos related to

Sort By:
Pageof 293
Journal of Reconstructive Microsurgery|February 16, 2021
Telehealth: Could It Be an Avenue to Microvascular Breast Reconstruction for Patients with Geographical Barriers?Salih Colakoglu, Ariel Johnson, Marc A M Mureau, et al.
Orthopedics|May 27, 2021
Clinical and Radiographic Predictors of Nonunion in Open Tibial Shaft FracturesAmy N Ford, Elizabeth A Harkin, Madeline M Lyons, et al.
The American Journal of Sports Medicine|January 2, 2024
Association Between Draft Order and Stress Sonography of the Ulnar Collateral Ligament of the Elbow in Professional Baseball Pitchers: An 18-Year StudyAdeeb J Hanna, John H Sonnier, Brian E Fliegel, et al.
Clinical Lung Cancer|November 14, 2017
Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II StudyCharu Aggarwal, Roger B Cohen, Eddy Yu, et al.
Orthopaedic Journal of Sports Medicine|March 3, 2018
Management of Elbow Dislocations in the National Football LeagueEdward S Chang, Meghan E Bishop, Christopher C Dodson, et al.
Genomics|November 1, 1992
A bone morphogenetic protein subfamily: chromosomal localization of human genes for BMP5, BMP6, and BMP7G V Hahn, R B Cohen, J M Wozney, et al.
Cancer Research|October 27, 1997
Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell linesO W Rokhlin, B S Hostager, G A Bishop, et al.
Orthopaedic Journal of Sports Medicine|April 25, 2024
Impact of Climate on Stress Ultrasound Findings of the Elbow Ulnar Collateral Ligament in Professional Baseball Pitchers: An 18-Year StudyAdeeb Jacob Hanna, Brian E Fliegel, John Hayden Sonnier, et al.
Cancer|May 20, 2016
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinomaJared M Weiss, Stephen Bagley, Wei-Ting Hwang, et al.
Clinical Rheumatology|January 1, 2022
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)Ruediger B Mueller, Hendrik Schulze-Koops, Daniel E Furst, et al.
Pageof 293